Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
This comparison outlines 2024 tax treatment differences between dividends from ETFs and mutual funds for informed decisions.
24,763 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
New heart health guidelines urge Lp(a) testing for at-risk adults, sending demand for diagnostics higher. This report...
More than 30 confirmed screwworm cases have been reported in Texas and New Mexico, including two dogs. Vets issue urg...
A Brooklyn rehab clinic case has public officials chasing a suspected scam spanning years. This article breaks down w...
A widow with $1.4 million in retirement assets faces a tax cliff once her spouse dies. The IRS treats her as a single...
Online fame built on controversy can bring money, but it also carries real financial risks. This article explains how...
If you keep cash in a basic checking or under the mattress, you may be missing out on meaningful growth. This guide s...
Curious about whether Blue Owl Capital can outperform the market? This guide breaks down what to watch, how to analyz...
Energy stocks are staging a comeback in 2026 as crude oil recovers and demand improves. The IYE ETF leads gains, sign...
Investors aiming to replace a $60,000 salary with monthly dividend ETFs face a simple math problem: how much capital ...
Bitwise promotes its new HYPE-based ETF, asserting the Gen 2 crypto token is undervalued. The move adds a new twist t...
SPYM and QQQ offer different paths to U.S. stock exposure. This guide explains when SPYM might fit a portfolio better...